Exact Mass: 365.16269980000004

Exact Mass Matches: 365.16269980000004

Found 162 metabolites which its exact mass value is equals to given mass value 365.16269980000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Trimethaphan

3,5-dibenzyl-4-oxo-8λ⁴-thia-3,5-diazatricyclo[6.3.0.0²,⁶]undecan-8-ylium

C22H25N2OS+ (365.16875)


Trimethaphan is only found in individuals that have used or taken this drug. It is a nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery. [PubChem]Trimethaphan is a ganglionic blocking agent prevents stimulation of postsynaptic receptors by competing with acetylcholine for these receptor sites. Additional effects may include direct peripheral vasodilation and release of histamine. Trimethaphans hypotensive effect is due to reduction in sympathetic tone and vasodilation, and is primarily postural. C - Cardiovascular system > C02 - Antihypertensives > C02B - Antiadrenergic agents, ganglion-blocking > C02BA - Sulfonium derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents

   

Propericiazine

10-[3-(4-hydroxypiperidin-1-yl)propyl]-10H-phenothiazine-2-carbonitrile

C21H23N3OS (365.15617480000003)


Propericiazine is a phenothiazine of the piperidine group. It has been shown to reduce pathologic arousal and affective tension in some psychotic patients, while the symptoms of abnormal mental integration are relatively unaffected. It is a sedative phenothiazine with weak antipsychotic properties. It also has adrenolytic, anticholinergic, metabolic and endocrine effects and an action on the extrapyramidal system. It is used as an adjunctive medication in some psychotic patients, for the control of residual prevailing hostility, impulsiveness and aggressiveness. Pericyazine, like other phenothiazines, is presumed to act principally in the subcortical areas, by producing what has been described as a central adrenergic blockade. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pericyazine (Propericiazine) is a first-generation antipsychotic agent that is used as an adjunct to the short-term management of severe anxiety states and psychosis[1]. Pericyazine is a selective D2-dopamine receptor antagonist[2][3]. Pericyazine has adrenolytic, anticholinergic, and extrapyramidal effects[4].

   

Isopentenyladenine-9-N-glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol

C16H23N5O5 (365.1699108)


Isopentenyladenine-9-N-glucoside belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Isopentenyladenine-9-N-glucoside is a strong basic compound (based on its pKa). Isopentenyladenine-9-N-glucoside is produced when isopentenyladenine and UDP-D-glucose react, with UDP as a byproduct. The reaction is catalyzed by UDP glycosyltransferases. Isopentenyladenine-9-N-glucoside is produced when isopentenyladenine and UDP-D-glucose react, with UDP as a byproduct. The reaction is catalyzed by UDP glycosyltransferases. [HMDB]

   

Nequinate

Methyl 6-butyl-1,4-dihydro-4-oxo-7-(phenylmethoxy)-3-quinolinecarboxylate, 9ci

C22H23NO4 (365.16269980000004)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent Antiprotozoan; used as a coccidiostat for poultry and rabbit

   

Timegadine

N-cyclohexyl-N-(2-methylquinolin-4-yl)-N-(1,3-thiazol-2-yl)guanidine

C20H23N5S (365.16740780000003)


   
   
   
   

N6-isopentenyladenine-9-glucoside (iP9G)

N6-isopentenyladenine-9-glucoside (iP9G)

C16H23N5O5 (365.1699108)


   

N6-isopentenyladenine-7-glucoside (iP7G)

N6-isopentenyladenine-7-glucoside (iP7G)

C16H23N5O5 (365.1699108)


   
   
   
   

Antibiotic KF 77AG6|B,HCl-Antibiotic KF 77AG6

Antibiotic KF 77AG6|B,HCl-Antibiotic KF 77AG6

C16H23N5O5 (365.1699108)


   
   

1-methylzeatine riboside|6-(4-hydroxy-1,3-dimethylbut-trans-2-enylamino)-9-beta-D-ribofuranosylpurine

1-methylzeatine riboside|6-(4-hydroxy-1,3-dimethylbut-trans-2-enylamino)-9-beta-D-ribofuranosylpurine

C16H23N5O5 (365.1699108)


   
   
   
   
   
   
   
   
   
   
   
   
   

Isopentenyl-Adenine-9-glucoside

Isopentenyl-Adenine-9-glucoside

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Isopentenyl-Adenine-7-glucoside

Isopentenyl-Adenine-7-glucoside

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

isopentenyl-Adenine-7-glucoside-[d6]

isopentenyl-Adenine-7-glucoside-[d6]

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

isopentenyl-Adenine-9-glucoside-[d6]

isopentenyl-Adenine-9-glucoside-[d6]

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

N6-Isopentenyladenine-7-glucoside

N6-Isopentenyladenine-7-glucoside

C16H23N5O5 (365.1699108)


   

N6-Isopentenyladenine-9-glucoside

N6-Isopentenyladenine-9-glucoside

C16H23N5O5 (365.1699108)


   

Periciazine

Propericiazine (oxide)

C21H23N3OS (365.15617480000003)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pericyazine (Propericiazine) is a first-generation antipsychotic agent that is used as an adjunct to the short-term management of severe anxiety states and psychosis[1]. Pericyazine is a selective D2-dopamine receptor antagonist[2][3]. Pericyazine has adrenolytic, anticholinergic, and extrapyramidal effects[4].

   
   
   
   

JWH 250 N-(5-carboxyxypentyl) metabolite

JWH 250 N-(5-carboxyxypentyl) metabolite

C22H23NO4 (365.16269980000004)


   

Statyl

Methyl 6-butyl-1,4-dihydro-4-oxo-7-(phenylmethoxy)-3-quinolinecarboxylate, 9ci

C22H23NO4 (365.16269980000004)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

Basic Violet 2

Basic Violet 2

C22H24ClN3 (365.16586540000003)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   
   

2-(4-BOC-PIPERAZINYL)-2-(3-NITRO-PHENYL)ACETIC ACID

2-(4-BOC-PIPERAZINYL)-2-(3-NITRO-PHENYL)ACETIC ACID

C17H23N3O6 (365.1586778)


   

Timegadine

Timegadine

C20H23N5S (365.16740780000003)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   
   

Prexasertib

Prexasertib

C18H19N7O2 (365.16001539999996)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   
   
   

Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-fluorophenyl)- (9CI)

Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-fluorophenyl)- (9CI)

C21H20FN3O2 (365.1539472)


   
   
   
   
   

Micafungin Side Chain Methyl Ester

Micafungin Side Chain Methyl Ester

C22H23NO4 (365.16269980000004)


   

2-(5-Norborene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium tetrafluoroborate

2-(5-Norborene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium tetrafluoroborate

C14H20BF4N3O3 (365.15337680000005)


   

(1R,2S)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYL-1-PROPANOL

(1R,2S)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYL-1-PROPANOL

C22H23NO4 (365.16269980000004)


   

(1S,2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)cyclohexane-1-carboxylic acid

(1S,2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)cyclohexane-1-carboxylic acid

C22H23NO4 (365.16269980000004)


   

(1S,2R)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYL-1-PROPANOL

(1S,2R)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYL-1-PROPANOL

C22H23NO4 (365.16269980000004)


   
   
   

methyl 2-(boc-piperazin-1-yl)-5-nitrobe&

methyl 2-(boc-piperazin-1-yl)-5-nitrobe&

C17H23N3O6 (365.1586778)


   
   

2-[1-(9H-fluoren-9-ylmethoxycarbonylamino)cyclopentyl]acetic acid

2-[1-(9H-fluoren-9-ylmethoxycarbonylamino)cyclopentyl]acetic acid

C22H23NO4 (365.16269980000004)


   
   

1-(1-ANTHRACENYLMETHYL)-4-(3-METHOXYPHENYL)-1H-[1,2,3]TRIAZOLE

1-(1-ANTHRACENYLMETHYL)-4-(3-METHOXYPHENYL)-1H-[1,2,3]TRIAZOLE

C24H19N3O (365.15280440000004)


   

[10-[(4-phenyltriazol-1-yl)methyl]anthracen-9-yl]methanol

[10-[(4-phenyltriazol-1-yl)methyl]anthracen-9-yl]methanol

C24H19N3O (365.15280440000004)


   

4-diphenylamino-4-biphenylboronic acid

4-diphenylamino-4-biphenylboronic acid

C24H20BNO2 (365.158701)


   
   

3-(TRIFLUOROMETHYL)[1,1-BIPHENYL]-4-SULFONYLCHLORIDE

3-(TRIFLUOROMETHYL)[1,1-BIPHENYL]-4-SULFONYLCHLORIDE

C17H23N3O6 (365.1586778)


   

(1R,2R)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID

(1R,2R)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID

C22H23NO4 (365.16269980000004)


   

1-(4-[PHENYLAZO]PHENYLAZO)-2-METHYLAMINONAPHTHALENE

1-(4-[PHENYLAZO]PHENYLAZO)-2-METHYLAMINONAPHTHALENE

C23H19N5 (365.16403740000004)


   

4-[(3-Methyl-1-benzothiophen-2-yl)methyl]-N-(3-pyridinyl)-1-piper idinecarboxamide

4-[(3-Methyl-1-benzothiophen-2-yl)methyl]-N-(3-pyridinyl)-1-piper idinecarboxamide

C21H23N3OS (365.15617480000003)


   

2-(4-BOC-PIPERAZINYL)-2-(2-NITRO-PHENYL)ACETIC ACID

2-(4-BOC-PIPERAZINYL)-2-(2-NITRO-PHENYL)ACETIC ACID

C17H23N3O6 (365.1586778)


   

1-(Fmoc-amino)cyclohexanecarboxylic acid

1-(Fmoc-amino)cyclohexanecarboxylic acid

C22H23NO4 (365.16269980000004)


   
   
   

Poly(1-hexadecene-sulfone)

Poly(1-hexadecene-sulfone)

C23H24ClNO (365.1546324)


   

(2R,4S)-4-([1,1-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid

(2R,4S)-4-([1,1-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid

C22H23NO4 (365.16269980000004)


   

3-fmoc-amino-cyclohexanecarboxylic acid

3-fmoc-amino-cyclohexanecarboxylic acid

C22H23NO4 (365.16269980000004)


   

(1S,2R)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID

(1S,2R)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID

C22H23NO4 (365.16269980000004)


   
   

(R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-2-yl)

(R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-2-yl)

C22H23NO4 (365.16269980000004)


   

(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-cyclobutyl

(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-cyclobutyl

C22H23NO4 (365.16269980000004)


   
   

5,6-bis[4-(dimethylamino)phenyl]-2-methyl-1,2,4-triazine-3-thione

5,6-bis[4-(dimethylamino)phenyl]-2-methyl-1,2,4-triazine-3-thione

C20H23N5S (365.16740780000003)


   
   

(S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-1,2,3,4-tetrahydroisoquinoline

(S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-1,2,3,4-tetrahydroisoquinoline

C20H22F3NO2 (365.1602548)


   

N-bis(N-methylanilino)phosphoryl-N-methylaniline

N-bis(N-methylanilino)phosphoryl-N-methylaniline

C21H24N3OP (365.1656904)


   

JWH 250 N-pentanoic acid metabolite

JWH 250 N-pentanoic acid metabolite

C22H23NO4 (365.16269980000004)


   

Isopentenyladenine-9-N-glucoside

Isopentenyladenine-9-N-glucoside

C16H23N5O5 (365.1699108)


   

7-(alpha-D-glucosyl)-N(6)-isopentenyladenine

7-(alpha-D-glucosyl)-N(6)-isopentenyladenine

C16H23N5O5 (365.1699108)


A glucosyl-N(6)-isopentenyladenine in which the glucosyl moiety is in the pyranose form, has alpha-D-configuration and is located at position N-7.

   

(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoyl]amino]-4-methylpentanoic acid

(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoyl]amino]-4-methylpentanoic acid

C14H28N3O6P (365.1715638)


   
   

Cathestatin B

Cathestatin B

C17H23N3O6 (365.1586778)


A carboxamide obtained by the formal condensation of the carboxylic group of oxirane-2,3-dicarboxylic acid with the amino group of N-(4-aminobutyl)-L-tyrosinamide (the 2S,3S stereoisomer). An antibiotic isolated from the fermentation broth of Penicillium citrinum, it acts as a potent inhibitor of cysteine protease.

   

2-[(1-Methyl-3-indolyl)thio]-1-(4-phenyl-1-piperazinyl)ethanone

2-[(1-Methyl-3-indolyl)thio]-1-(4-phenyl-1-piperazinyl)ethanone

C21H23N3OS (365.15617480000003)


   

(2R,4S)-2-(3-((phenylcarbamoyl)methylcarbamoyl)propyl)-4-aminopentanedioic acid

(2R,4S)-2-(3-((phenylcarbamoyl)methylcarbamoyl)propyl)-4-aminopentanedioic acid

C17H23N3O6 (365.1586778)


   

5-(4-fluorophenyl)-N-[2-(1-piperidinyl)phenyl]-4-oxazolecarboxamide

5-(4-fluorophenyl)-N-[2-(1-piperidinyl)phenyl]-4-oxazolecarboxamide

C21H20FN3O2 (365.1539472)


   

1-[1-[(4-Fluorophenyl)methyl]-5-methyl-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea

1-[1-[(4-Fluorophenyl)methyl]-5-methyl-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea

C21H20FN3O2 (365.1539472)


   

[[4-(Dimethylamino)phenyl]-(2-methylpropoxy)phosphoryl]-(2-fluorophenyl)methanol

[[4-(Dimethylamino)phenyl]-(2-methylpropoxy)phosphoryl]-(2-fluorophenyl)methanol

C19H25FNO3P (365.15560020000004)


   

[1-[(1-Ethyl-4-pyrazolyl)methyl]-3-piperidinyl]-[3-(trifluoromethyl)phenyl]methanone

[1-[(1-Ethyl-4-pyrazolyl)methyl]-3-piperidinyl]-[3-(trifluoromethyl)phenyl]methanone

C19H22F3N3O (365.1714878)


   

N-hippuryl-N(6)-(carboxymethyl)lysine

N-hippuryl-N(6)-(carboxymethyl)lysine

C17H23N3O6 (365.1586778)


   
   
   
   
   

(2R,3R,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

(2R,3R,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2R,3S,4S)-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile

(2R,3S,4S)-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile

C21H23N3OS (365.15617480000003)


   

(2R,3R,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

(2R,3R,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2S,3R,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

(2S,3R,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2R,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

(2R,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2S,3R,4R)-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile

(2S,3R,4R)-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile

C21H23N3OS (365.15617480000003)


   

(2S,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(4-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2S,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(4-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2R,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2S,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

(2S,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2S,3S,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

(2S,3S,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(4-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(4-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   

(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C21H23N3OS (365.15617480000003)


   
   
   
   
   
   
   
   
   

beta-D-Tyvp-(1->3)-beta-D-GalpNAc-OMe

beta-D-Tyvp-(1->3)-beta-D-GalpNAc-OMe

C15H27NO9 (365.16857319999997)


   

(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoylamino]-5-(diaminomethylideneamino)pentanoic acid

(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoylamino]-5-(diaminomethylideneamino)pentanoic acid

C16H23N5O5 (365.1699108)


   

1,1-Dimethyl-4-trimethylsilyl-5-phenyl-3-(o-tolyl)-1,3-disila-4-cyclopentene

1,1-Dimethyl-4-trimethylsilyl-5-phenyl-3-(o-tolyl)-1,3-disila-4-cyclopentene

C21H29Si3 (365.1576974)


   

TRIMETHAPHAN

TRIMETHAPHAN

C22H25N2OS+ (365.16875)


C - Cardiovascular system > C02 - Antihypertensives > C02B - Antiadrenergic agents, ganglion-blocking > C02BA - Sulfonium derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents

   

Nequinate

Nequinate

C22H23NO4 (365.16269980000004)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

(20r,21s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol

(20r,21s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol

C22H23NO4 (365.16269980000004)


   

8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one

8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one

C22H23NO4 (365.16269980000004)


   

5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol

5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol

C22H23NO4 (365.16269980000004)


   

5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-6,10-diol

5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-6,10-diol

C22H23NO4 (365.16269980000004)


   

(2s,3s,4r,5s,6r)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxane-3,4,5-triol

(2s,3s,4r,5s,6r)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxane-3,4,5-triol

C16H23N5O5 (365.1699108)


   

(7s)-6',7'-dimethoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]

(7s)-6',7'-dimethoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]

C22H23NO4 (365.16269980000004)


   

(20s,21s)-10,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,21-diol

(20s,21s)-10,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,21-diol

C22H23NO4 (365.16269980000004)


   

(2r,3r,4s,5r)-2-(6-{[(2r,3e)-5-hydroxy-4-methylpent-3-en-2-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-(6-{[(2r,3e)-5-hydroxy-4-methylpent-3-en-2-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O5 (365.1699108)


   

(5e)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one

(5e)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one

C22H23NO4 (365.16269980000004)


   

8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,6-dien-4-one

8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,6-dien-4-one

C22H23NO4 (365.16269980000004)


   

(2e,4e,6e)-7-{10-[(1e,3e)-4-(c-hydroxycarbonimidoyl)buta-1,3-dien-1-yl]-3-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,8-dien-2-yl}hepta-2,4,6-trienoic acid

(2e,4e,6e)-7-{10-[(1e,3e)-4-(c-hydroxycarbonimidoyl)buta-1,3-dien-1-yl]-3-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,8-dien-2-yl}hepta-2,4,6-trienoic acid

C22H23NO4 (365.16269980000004)


   

(20s,21r)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol

(20s,21r)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol

C22H23NO4 (365.16269980000004)


   

(20s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-6,10-diol

(20s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-6,10-diol

C22H23NO4 (365.16269980000004)


   

(5z)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one

(5z)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one

C22H23NO4 (365.16269980000004)


   

6-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

6-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C22H23NO4 (365.16269980000004)


   

7-hydroxy-5-methoxy-8-(1-methylpiperidin-2-yl)-2-phenylchromen-4-one

7-hydroxy-5-methoxy-8-(1-methylpiperidin-2-yl)-2-phenylchromen-4-one

C22H23NO4 (365.16269980000004)


   

(2s,3s)-3-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

(2s,3s)-3-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

C17H23N3O6 (365.1586778)


   

3-({1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

3-({1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

C17H23N3O6 (365.1586778)


   

6',7'-dimethoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]

6',7'-dimethoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]

C22H23NO4 (365.16269980000004)


   

2-{[2-({2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene}amino)-1-hydroxypropylidene]amino}-4-methylpentanoic acid

2-{[2-({2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene}amino)-1-hydroxypropylidene]amino}-4-methylpentanoic acid

C14H28N3O6P (365.1715638)


   

(6e)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,6-dien-4-one

(6e)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,6-dien-4-one

C22H23NO4 (365.16269980000004)


   

7-[10-(4-carbamoylbuta-1,3-dien-1-yl)-3-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,8-dien-2-yl]hepta-2,4,6-trienoic acid

7-[10-(4-carbamoylbuta-1,3-dien-1-yl)-3-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,8-dien-2-yl]hepta-2,4,6-trienoic acid

C22H23NO4 (365.16269980000004)


   

(20s)-6,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,10-diol

(20s)-6,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,10-diol

C22H23NO4 (365.16269980000004)


   

10,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,21-diol

10,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,21-diol

C22H23NO4 (365.16269980000004)


   

2-{6-[(5-hydroxy-4-methylpent-3-en-2-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

2-{6-[(5-hydroxy-4-methylpent-3-en-2-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O5 (365.1699108)


   

(20s,21s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol

(20s,21s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol

C22H23NO4 (365.16269980000004)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene]amino}-1-hydroxypropylidene]amino}-4-methylpentanoic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene]amino}-1-hydroxypropylidene]amino}-4-methylpentanoic acid

C14H28N3O6P (365.1715638)


   

(1r,3r,5s,6r)-6-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

(1r,3r,5s,6r)-6-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C22H23NO4 (365.16269980000004)


   

6,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,10-diol

6,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,10-diol

C22H23NO4 (365.16269980000004)